Comparison of placement of the inflated transcervical Foley catheter for 6 or 12 hours in the labour induction of women with one previous Caesarean birth

ISRCTN ISRCTN58643025
DOI https://doi.org/10.1186/ISRCTN58643025
Secondary identifying numbers 2021108-10681
Submission date
16/01/2022
Registration date
19/01/2022
Last edited
11/06/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Induction of labour (IOL) and Caesarean delivery are common obstetric procedures. Their occurrences are generally still increasing so it is increasingly common to have women with a previous Caesarean coming forward for IOL. IOL in women with a previous Caesarean is a higher risk procedure as there is a small risk of uterine rupture and a considerable risk of unsuccessful IOL requiring unplanned Caesarean delivery. However, in motivated and informed women delivering within a fully-resourced care setting, IOL after previous Caesarean is an acceptable practice as vaginal birth after Caesarean is associated with less morbidity (illness) for the mother and there is less risk of complications in future pregnancies.
Time to delivery is an important consideration during IOL because of its association with increased risk of Caesarean delivery, postpartum hemorrhage (bleeding after giving birth), and maternal and newborn infections. Moreover, a lengthy IOL process can burden busy delivery wards, increase healthcare costs and lower patient satisfaction.
A Foley catheter is a low-cost, long, flexible tube with a balloon at one end that can be inflated after insertion with sterile water. The Foley catheter is inserted through the neck of the womb (cervix) with the balloon then inflated just beyond to slowly dilate the cervix. A partially opened cervix then provides access to break the waters to help bring on labour pains. Studies have compared balloon placement for 6 compared to 12 hours with the use of a proprietary double-balloon catheter, finding that 6-hour placement hastens delivery. The aim of this study is to evaluate the placement of a low-cost single balloon Foley catheter for 6 vs 12 hours in women who have one previous caesarean section with closed cervixes undergoing IOL on the interval between catheter insertion to the birth of the baby.

Who can participate?
Women aged 18 years and over at term with one previous Caesarean and planned for IOL

What does the study involve?
The Foley catheter is typically inserted through the vagina into the lower womb. The balloon near the tip of the catheter is then inflated with 80 ml of sterile water. After the balloon has been inflated and retained, the external tubing of the catheter will be taped to the inner thigh and the participant can move around freely and perform bodily functions without any impairment.
Once the catheter balloon has been placed, the fetal heart rate and contractions if any will be monitored for a short time to ensure the situation is reassuring. Then participants will be randomly assigned to one of the two interventions with an equal chance of being assigned to either group (i.e., removal of the catheter at 6 or 12 hours).

What are the possible benefit and risks of participating?
Different placement intervals before planned removal of the Foley catheter may or may not impact the interval to birth. Apart from the time to birth, the study is not anticipated to have an effect on other mother or baby outcomes. Major adverse outcomes arising from the interventions are not anticipated. Despite balloon ripening of the cervix, up to 90% of women induced with the Foley catheter require breaking of waters and a hormone drip to initiate contractions. Participants allocated to 6-hour placement may find that their cervix has not opened enough for their forewaters to be ruptured and further ripening is needed. If that is the case, options are available to continue the ripening.

Where is the study run form?
University Malaya Medical Centre (Malaysia)

When is the study starting and how long is it expected to run for?
September 2021 to February 2023

Who is funding the study?
University Malaya (Malaysia)

Who is the main contact?
1. Dr Usha Yogamoorthy
y.usha@ummc.edu.my
2. Prof. Dr Tan Peng Chiong
pctan@um.edu.my

Contact information

Dr Usha Yogamoorthy
Principal Investigator

University Malaya Medical Centre
Kuala Lumpur
59100
Malaysia

ORCiD logoORCID ID 0000-0003-2836-3201
Phone +60 (0)379494422
Email y.usha@ummc.edu.my

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet 40948_PIS_v1_07Oct2021.pdf
Scientific titleFoley catheter placement for labour induction in one previous Caesarean with unripe cervices for 6 compared to 12 hours: a randomised trial
Study acronymFOLIC
Study objectivesIt is hypothesized that induction of labour with planned Foley catheter removed at 6 compared to 12 hours in women with one previous Caesarean delivery will result in a shorter time to birth.
Ethics approval(s)Approved 03/01/2022, University of Malaya Medical Centre Medical Research Ethics Committee (Lembah Pantai, 59100 Kuala Lumpur, Malaysia, +60 (0)379498473; ummc-mrec@ummc.edu.my), ref: MREC ID: 2021108-10681
Health condition(s) or problem(s) studiedInduction of labour
InterventionWomen with a history of one previous lower segment Caesarean section who are at term with unripe cervixes and have had Foley catheter placed trans-cervically and its balloon inflated for induction of labour will be randomised (using random.org application) to either catheter placement before planned removal at:
A) 6 hours or
B) 12 hours

Following Foley catheter placement to its planned removal, management is reactive. Vaginal examination and pulling on the Foley catheter to check dislodgement are avoided. If there are painful contractions, waters break, excessive vaginal bleeding, abnormal fetal heart rate tracing, fever, or concerning features, then vaginal examination followed by catheter removal, amniotomy, and oxytocin infusion may occur as appropriate within the 6- or 12-hour trial intervention periods in an appropriate response. In the event that the balloon is expelled spontaneously within the 6- or 12-hour trial intervention intervals, the usual actions to carry on with labour induction will be instituted.
Intervention typeProcedure/Surgery
Primary outcome measureFoley catheter insertion to birth interval (hours) measured using patient records
Secondary outcome measuresMaternal outcomes:
1. Estimate of the readiness of the cervix for labour measured using Bishop score calculated before insertion of the catheter and after removal of the catheter
2. Use of additional method for cervical ripening measured from patient records after removal of the catheter
3. Time to delivery after Foley removal measured from patient records between removal of the catheter and delivery
4. Mode of delivery measured from patient records at delivery
5. Indication for caesarean section measured from patient record at delivery
6. Duration of oxytocin infusion measured from patient records between delivery to discharge
7. Maternal satisfaction-based allocation to intervention until birth measured using 11-point Verbal Numerical Rating Score (VNRS) at delivery
8. Blood loss during delivery measured from patient records at delivery
9. Third -or fourth-degree tear measured from patient records at delivery
10. Maternal infection measured from patient records between admission and discharge
11. Use of regional analgesia in labour measured from patient records at delivery
12. Length of hospital stay measured from patient records between hospital admission and discharge
13. Need for ICU admission measured from patient records between hospital admission and discharge
14. Cardiorespiratory arrest measured from patient record between hospital admission and discharge
15. Need of hysterectomy measured from patient record between admission and discharge.
16. Uterine scar rupture / dehiscence measured from patient record between hospital admission and discharge

Neonatal outcomes:
1. Neonatal health measured using Apgar score at 1 and 5 min after delivery
2. Need for NICU admission measured from patient records between hospital admission and discharge
3. Cord pH measured at delivery
4. Neonatal sepsis measured from patient records between delivery and discharge
5. Birth weight measured from patient records at delivery
6. Birth trauma measured from patient records at delivery
7. Hypoxic ischemic encephalopathy/need for therapeutic hypothermia measured from patient records between delivery to discharge
Overall study start date15/09/2021
Completion date24/02/2023

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants126
Total final enrolment126
Key inclusion criteria1. One previous transverse lower segment Caesarean delivery
2. Bishop score ≤ 5
3. Age ≥18 years
4. Term pregnancy >36 weeks gestation
5. Singleton pregnancy
6. Cephalic presentation
7. Intact membrane
8. Reassuring fetal heart rate tracing
9. Absence of significant contraction ≥2 in 10 minutes
10. Successful Foley catheter insertion
Key exclusion criteria1. History of hysterotomy/uterine perforation/myomectomy
2. Preference for repeat caesarean section
3. Latex allergy
4. Estimated fetal weight <2 kg or >4 kg
5. Placenta previa including minor previa
6. Major fetal malformations
7. Contraindication for vaginal delivery
8. Patient who is suspected COVID-19 infection or SARS-CoV-2 positive
9. Inability to given consent
Date of first enrolment25/01/2022
Date of final enrolment10/02/2023

Locations

Countries of recruitment

  • Malaysia

Study participating centre

University Malaya Medical Centre
Lembah Pantai
Kuala Lumpur
59100
Malaysia

Sponsor information

University Malaya Medical Centre
Hospital/treatment centre

Jalan Lembah Pantai
Kuala Lumpur
59100
Malaysia

Phone +60 (0)379492049
Email ummc@ummc.edu.my
Website http://www.ummc.edu.my/#
ROR logo "ROR" https://ror.org/00vkrxq08

Funders

Funder type

University/education

Universiti Malaya
Government organisation / Universities (academic only)
Alternative name(s)
University of Malaya, University Malaya, Malayan University, UM
Location
Malaysia

Results and Publications

Intention to publish date24/02/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal.
IPD sharing planThe raw data generated during and/or analyzed during the current study are/will be available upon request from Dr Usha Yogamoorthy (y.usha@ummc.edu.my) subject to institutional review board approval.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version 1 07/10/2021 18/01/2022 No Yes
Protocol file version 1 07/10/2021 18/01/2022 No No
Results article 19/09/2023 11/06/2025 Yes No

Additional files

40948_PIS_v1_07Oct2021.pdf
40948 Protocol_v1_07Oct2021.pdf

Editorial Notes

11/06/2025: Publication reference and total final enrolment added.
09/05/2023: The following changes have been made:
1. The recruitment end date has been changed from 30/05/2022 to 10/02/2023.
2. The overall trial end date has been changed from 31/05/2023 to 24/02/2023 and the plain English summary updated accordingly.
3. The intention to publish date has been changed from 01/09/2023 to 24/02/2024.
4. The ethics approval date has been changed from 20/10/2021 to 03/01/2022.
17/02/2022: The recruitment start date was changed from 31/01/2022 to 25/01/2022.
18/01/2022: Trial's existence confirmed by University of Malaya Medical Centre Medical Research Ethics Committee